Coles Wind Farm conversations continue
The project would see Apex Clean Energy building 51 wind turbines along Illinois Route 130, north of Charleston in Coles County.
PREVIOUSLY: Coles Wind makes their case for a county wind farm
They discussed the project itself and answered questions and concerns from county board officials and community members throughout Coles County. Questions and concerns were directed towards several experts who provided testimony on behalf of several studies.
'As a developer, I know a lot about the project, but I'm not an economist, nor am I a wildlife biologist. So we feel like it's important to have the people who did the studies here in the room so that they can answer the questions of the board and really speak to the work that they did on the project.' said Alan Moore, a director of development for Apex Clean Energy.
The meeting marked another step in the process for Apex Clean Energy to obtain a special use permit. Moore said there will be more public hearings into next week.
The company hopes to submit building permits this summer and break ground either later this year or early next year.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
12 hours ago
- Business Insider
All Eyes on Nvidia Stock Ahead of Earnings; Here's What Morgan Stanley Expects
Nvidia (NASDAQ:NVDA) stock heads into the last stretch of earnings season carrying sky-high expectations. Investors will get their answers on August 27, as the AI heavyweight reports against a backdrop of strength across the sector. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. And that strength is no coincidence. The billion-dollar spending spree among hyperscalers is going full steam ahead, while TSMC, the world's largest chip foundry, delivered robust results in its Q2 2025 earnings report last month. Add to that sovereign efforts to build national AI initiatives, the race toward physical AI, and the recent easing of China's export restrictions, and the environment looks tailor-made for Nvidia's continued momentum. Against this backdrop, Nvidia has set a high bar, guiding for fiscal second-quarter revenues of $45 billion plus or minus 2%, with margins expected to be north of 70%. If achieved, that would mean 50% year-over-year growth – remarkable for any company, let alone one already valued at over $4 trillion. Still, Morgan Stanley's Joseph Moore, a 5-star analyst ranked among the top 4% on TipRanks, urges some caution in the near term, noting that while Nvidia is well-positioned for the long haul, expectations for the current quarter may be tempered. 'We expect a strong quarter and outlook, but we're a little measured on the current quarter – our optimism centers on what lies ahead,' Moore explains. The analyst points to the Blackwell ramp as the next major growth engine, while also highlighting tier-2 customers – often overlooked – as an underappreciated source of strength heading into the second half of the year. China adds another wrinkle. While Nvidia may be conservative in forecasting sales there due to the uncertainty around export licenses, those revenues could eventually provide another tailwind. And with R&D spending surpassing $15 billion annually, Nvidia's grip on the data center market looks secure. Taken together, Moore argues the demand story is intact and only growing stronger. 'Supply is what matters on the night of the earnings call, but demand is what sets the path into 2026, where all indications are positive,' the analyst sums up, assigning NVDA with a Buy rating and $206 price target, which implies ~17% above current levels. (To watch Moore's track record, click here) That outlook aligns closely with the broader Street view. Nvidia boasts 35 Buys, 2 Holds, and just 1 Sell, giving it a Strong Buy consensus. The average 12-month price target of $197.03 implies ~12% upside for the next 12 months. (See NVDA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
a day ago
- Yahoo
NVDA: Morgan Stanley Says 'Time to Power Up' Nvidia Ahead of Earnings
Aug 19 - Morgan Stanley raised its price target on Nvidia and told investors now feels like time to power up for the chipmaker, sending fresh optimism into the market ahead of Nvidia's Aug. 27 Q2 FY26 report. Morgan Stanley's Joseph Moore kept a "Buy" view and nudged the target to $206, citing strong, ongoing customer demand and improving supply for Blackwell GPUs. He now models higher revenue and EPS for 2026, reflecting faster rack assembly and more shipments expected later this year and into early 2026. Warning! GuruFocus has detected 5 Warning Signs with NVDA. Moore also expects Nvidia to hold roughly an 85% market share in AI datacenter chips next year, leaving rivals with a steep catch-up task. The analyst sees July and October revenue beats relative to prior estimates and raised his 2026 revenue/EPS outlook accordingly. While China licensing and supply variables could influence near-term results, the firm's updated forecasts underline a durable demand backdrop from hyperscale cloud customers and growing traction among smaller cloud buyers. That mix helps explain why Wall Street looks bullish heading into the quarter. This article first appeared on GuruFocus.
Yahoo
a day ago
- Yahoo
Iowa State University, industry partners to elevate biobased product testing
The Iowa State University BioCentury Research Farm will house a new multi-use fermentation facility in partnership with BioMADE. (Photo courtesy of Iowa State University) Iowa State University is working with a U.S. Defense Department-backed organization to develop facilities that could make the university and its community a national destination for biobased product testing. BioMADE, a Manufacturing Innovation Institute focused on bioindustrial manufacturing and supported by the U.S. Department of Defense, announced it has partnered with ISU and the ISU Research Park to create and operate a multiuse fermentation facility. The $40 million project, funded with contributions from the Iowa Economic Development and Finance Authority, BioMADE and Iowa State, will be housed at the university's BioCentury Research Farm outside of Ames. Kevin Moore, chief technology officer of the Biobased Products team in the office of the vice president for research, said the announcement brings to fruition work that was started by the state to strengthen biosciences industries in Iowa. He expects the program to be up and running in early 2028, and the new facility will utilize existing infrastructure to operate. 'This is why the state has invested money in this kind of effort, is that so we would have resources that could go after this opportunity,' Moore said. 'And that's what we did, and we're going forward.' SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX The Biobased Products team at ISU was created as part of a statewide biosciences initiative, Moore said, with the goal of promoting economic development in related industries. Much of Moore's job is working with ISU faculty to commercialize ideas or products they've developed through startup companies, he said. Fermentation is best known for its role in the beer-making process, Moore said, but it also has a hand in making enzymes that can be found in detergents and other items, natural products like vitamin C, bioplastics and more. The university already has fermentation abilities, Moore said, but on a much smaller scale. The ISU Center for Crops Utilization Research houses a fermentation facility with equipment that goes up to 1,000 liters, where companies can test products on a small scale and complete 'proof of concept' work, but the new space will scale capabilities up to 10,000 liters. Moore said the goal behind the new facility is to bring in companies to test their products before they have to decide whether to invest in customized, full-scale facilities of their own to mass-produce it. 'The key purpose of the announced facility is to de-risk investment decisions so that we can diversify the products that are made from corn, and also enable all of the various technologies that are being developed via fermentation, allowing them to come to reality,' Moore said. As Iowa has plenty of feedstock and the need to diversify how corn is used, Moore said, and this new partnership provides opportunities to address both of these facts. As the facilities will be managed by BioMADE and aimed at industry development, Moore said it is unlikely much research coming from ISU will be conducted there. Companies based in Iowa like Cargill and Kent Worldwide are expected to make use of the facilities, Moore said, as well as national and international partners of BioMADE. 'We do envision that some faculty members and their startup companies could be users of the facility, but really we view this as a national resource,' Moore said. SUPPORT: YOU MAKE OUR WORK POSSIBLE Solve the daily Crossword
